Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by WatchLearnEarnon Aug 06, 2017 10:44pm
137 Views
Post# 26553091

RE:RE:RE:RE:RE:RE:RE:RE:Sometimes I wonder....

RE:RE:RE:RE:RE:RE:RE:RE:Sometimes I wonder....I definitely think Phase 1, Part 2 (6 patients, therapeutic dose) is already underway given the May 26 recommendation to move forward. That's 2-1/2  months ago. They haven't been sitting on their hands all this time.

LaserStock29 wrote: Who wants to bet that patient 5 was last week and patient 6 is this week.

:-)

End of august we should have all 6 done imo  (Aug 28-31st)  I would hope Roger does a PR on the last of the 6 treated. 

Then the Phase 2 dsab & HC official approval takes place End of September after the last of the 6 patients does their safety.

The first safety is August 19th (13 days!)  time flies eh boys.. that will be a very nice indication.

If the profiles mimic the first 3 low dose. i.e drug in bladder ratio to blood 800 to 1.5.

We're golden. 




macman1519 wrote: Well reasoned, fred. My issue is now, an opportunit exists now for the betterment of all shareholders, that has really never exixted. Take advantage of it to improve everything. He chooses to allow the manipulation, chooses to ignore a strategy that would  lead to improved pr, cashed warrants, the end of manipulation.  His solution is to wait, for what, a rediculous pp for mr frost????? Watch, its coming. And for why, why????? A better solution is staring you in the face 
F O R   S A L E  WHAT IS THE FRIGG8N DOWNSIDE????????? 


quote=fredgoodwinson]Big Pharma takes an average of $1.2bn to bring a new drug to the Clinic and if their genii were in charge - as for some mysterious reason a few here seem to wish - we could have over 3.5bn shares in issue just to have got to this stage.

So it has been a quite brilliant economy on the part of Roger White to get us here with a mere 124m shares to date and however frustrated this leaves bashers and market manipulators alike true logs remain very pleased with what RW has done and is surely doing right now.




[/quote]

Bullboard Posts